The National Institutes of Health (NIH) is cutting or canceling more than 40 grants focused on vaccine hesitancy and ways to increase vaccine acceptance, accord ...
HealthDay News — The majority of people are unaware that the human papillomavirus (HPV) is more common among men and is associated with rising rates of cancers that directly impact men, according to ...
HealthDay News — Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications, according to a study presented at ...
"The most effective health-promoting solution would be to effectively end food insecurity through social policies and an augmented social safety net." ...
Vepdegestrant is a novel proteolysis targeting chimera protein degrader designed to target and degrade the estrogen receptor.
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...
Several lots of intravenous and subcutaneous immune globulin have been voluntarily withdrawn by the manufacturers as a precautionary measure due to increased reports of allergic/hypersensitivity type ...
Johnson & Johnson is ending the phase 3 VENTURA clinical development program evaluating aticaprant, a selective kappa receptor antagonist, as an adjunctive treatment for major depressive disorder (MDD ...
Years of research involving hundreds of thousands of children have found no link between autism and vaccines. HealthDay News — The US Centers for Disease Control and Prevention (CDC) is preparing to ...
GLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin ...
“Our trial showed that treating male partners with a week of oral metronidazole and topical clindamycin, together with treatment of women, resulted in a lower rate of recurrence of bacterial vaginosis ...
The survey revealed that 18% of young adults aged 18 to 29 years needed to borrow money to pay health care costs. Adults aged 30 to 49 years reported similar rates. However, only 9 and 2% of Americans ...